95 related articles for article (PubMed ID: 8806180)
1. Two evolutionary strategies of influenza viruses to escape host non-specific inhibitors: alteration of hemagglutinin or neuraminidase specificity.
Gimsa U; Grötzinger I; Gimsa J
Virus Res; 1996 Jun; 42(1-2):127-35. PubMed ID: 8806180
[TBL] [Abstract][Full Text] [Related]
2. Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants.
Rogers GN; Pritchett TJ; Lane JL; Paulson JC
Virology; 1983 Dec; 131(2):394-408. PubMed ID: 6197808
[TBL] [Abstract][Full Text] [Related]
3. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin.
Rogers GN; Paulson JC
Virology; 1983 Jun; 127(2):361-73. PubMed ID: 6868370
[TBL] [Abstract][Full Text] [Related]
4. Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses.
Gulati U; Wu W; Gulati S; Kumari K; Waner JL; Air GM
Virology; 2005 Aug; 339(1):12-20. PubMed ID: 15950996
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of serum resistance of human influenza H3N2 virus and their involvement in virus adaptation in a new host.
Matrosovich M; Gao P; Kawaoka Y
J Virol; 1998 Aug; 72(8):6373-80. PubMed ID: 9658077
[TBL] [Abstract][Full Text] [Related]
6. H3N2 influenza viruses in humans: Viral mechanisms, evolution, and evaluation.
Allen JD; Ross TM
Hum Vaccin Immunother; 2018; 14(8):1840-1847. PubMed ID: 29641358
[TBL] [Abstract][Full Text] [Related]
7. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
[TBL] [Abstract][Full Text] [Related]
8. Consecutive natural influenza a virus infections in sentinel mallards in the evident absence of subtype-specific hemagglutination inhibiting antibodies.
Globig A; Fereidouni SR; Harder TC; Grund C; Beer M; Mettenleiter TC; Starick E
Transbound Emerg Dis; 2013 Oct; 60(5):395-402. PubMed ID: 22816511
[TBL] [Abstract][Full Text] [Related]
9. Changes in H3 influenza A virus receptor specificity during replication in humans.
Ryan-Poirier K; Suzuki Y; Bean WJ; Kobasa D; Takada A; Ito T; Kawaoka Y
Virus Res; 1998 Aug; 56(2):169-76. PubMed ID: 9783465
[TBL] [Abstract][Full Text] [Related]
10. The N2 neuraminidase of human influenza virus has acquired a substrate specificity complementary to the hemagglutinin receptor specificity.
Baum LG; Paulson JC
Virology; 1991 Jan; 180(1):10-5. PubMed ID: 1984642
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding properties of human and animal H1 influenza virus isolates.
Rogers GN; D'Souza BL
Virology; 1989 Nov; 173(1):317-22. PubMed ID: 2815586
[TBL] [Abstract][Full Text] [Related]
12. Demonstration of antibodies to both hemagglutinin and neuraminidase antigens of H3N2 influenza A virus in domestic dogs.
Kilbourne ED; Kehoe JM
Intervirology; 1975-1976; 6(4-5):315-8. PubMed ID: 1235862
[TBL] [Abstract][Full Text] [Related]
13. Hemagglutinin Stalk- and Neuraminidase-Specific Monoclonal Antibodies Protect against Lethal H10N8 Influenza Virus Infection in Mice.
Wohlbold TJ; Chromikova V; Tan GS; Meade P; Amanat F; Comella P; Hirsh A; Krammer F
J Virol; 2016 Jan; 90(2):851-61. PubMed ID: 26512088
[TBL] [Abstract][Full Text] [Related]
14. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics.
Lu B; Zhou H; Ye D; Kemble G; Jin H
J Virol; 2005 Jun; 79(11):6763-71. PubMed ID: 15890915
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the hemagglutinin receptor specificity and neuraminidase substrate specificity of clinical isolates of human influenza A viruses.
Couceiro JN; Baum LG
Mem Inst Oswaldo Cruz; 1994; 89(4):587-91. PubMed ID: 8524060
[TBL] [Abstract][Full Text] [Related]
16. Interdependence of hemagglutinin glycosylation and neuraminidase as regulators of influenza virus growth: a study by reverse genetics.
Wagner R; Wolff T; Herwig A; Pleschka S; Klenk HD
J Virol; 2000 Jul; 74(14):6316-23. PubMed ID: 10864641
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies.
Kaverin NV; Rudneva IA; Govorkova EA; Timofeeva TA; Shilov AA; Kochergin-Nikitsky KS; Krylov PS; Webster RG
J Virol; 2007 Dec; 81(23):12911-7. PubMed ID: 17881439
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies differentially affect the interaction between the hemagglutinin of H9 influenza virus escape mutants and sialic receptors.
Ilyushina N; Rudneva I; Gambaryan A; Bovin N; Kaverin N
Virology; 2004 Nov; 329(1):33-9. PubMed ID: 15476872
[TBL] [Abstract][Full Text] [Related]
19. Antigenic and genetic characteristics of H1N1 human influenza virus isolated from pigs in Japan.
Katsuda K; Sato S; Shirahata T; Lindstrom S; Nerome R; Ishida M; Nerome K; Goto H
J Gen Virol; 1995 May; 76 ( Pt 5)():1247-9. PubMed ID: 7730809
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation of Hemagglutinin and Neuraminidase of Influenza A Virus as Signature for Ecological Spillover and Adaptation among Influenza Reservoirs.
Kim P; Jang YH; Kwon SB; Lee CM; Han G; Seong BL
Viruses; 2018 Apr; 10(4):. PubMed ID: 29642453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
